US 12397028
Adoptive cellular therapy
granted A61KA61K2039/5256A61K35/763
Quick answer
US patent 12397028 (Adoptive cellular therapy) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/5256, A61K35/763, A61K40/10, A61K40/31